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Peptidoglycan (PG), a complex polymer composed of saccharide
chains cross-linked by short peptides, is a critical component of the
bacterial cell wall. PG synthesis has been extensively studied in
model organisms but remains poorly understood in mycobacteria,
a genus that includes the important human pathogen Mycobacte-
rium tuberculosis (Mtb). The principle PG synthetic enzymes have
similar and, at times, overlapping functions. To determine how these
are functionally organized, we carried out whole-genome transposon
mutagenesis screens in Mtb strains deleted for ponA1, ponA2, and
ldtB, major PG synthetic enzymes. We identified distinct factors
required to sustain bacterial growth in the absence of each of these
enzymes. We find that even the homologs PonA1 and PonA2 have
unique sets of genetic interactions, suggesting there are distinct PG
synthesis pathways in Mtb. Either PonA1 or PonA2 is required for
growth of Mtb, but both genetically interact with LdtB, which has
its own distinct genetic network. We further provide evidence that
each interaction network is differentially susceptible to antibiotics.
Thus, Mtb uses alternative pathways to produce PG, each with its
own biochemical characteristics and vulnerabilities.
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One of the leading causes of infectious disease deaths world-wide is tuberculosis (TB), caused by Mycobacterium tubercu-
losis (Mtb). One-third of the human population is thought to
harbor Mtb and ∼1.5 million individuals died of TB last year (1).
Mtb’s success as a pathogen is due in part to its unusual cell wall,
which is notorious for its complexity and is implicated in Mtb’s
innate resistance to many commonly used antibiotics (2). A
critical component of the bacterial cell wall (including Mtb’s) is
peptidoglycan (PG), a complex polymer that provides structural
support and counteracts turgor pressure (3). PG is essential for
cell survival, and its synthesis is targeted by many potent anti-
biotics (2).
PG consists of long glycan chains composed of two different
sugars (Fig. 1A) that are cross-linked via short peptide side
chains that extend from the glycan chains. Notably, generation of
mature PG occurs outside of the cell membrane and is mediated
by enzymes that incorporate new PG subunits, which are formed
in the cytoplasm, into the PG polymer. PonA1 and PonA2 are
the two enzymes in Mtb that can both polymerize glycan strands
and cross-link peptides [known as bifunctional penicillin binding
proteins (PBPs), Fig. 1A]. The predominant peptide cross-links
in mycobacteria join the third amino acids (3–3 link) of adjacent
stem peptides (4, 5), which are synthesized by L,D-transpeptidases
(Ldts) such as LdtB, one of the major Ldts in Mtb (Fig. 1A). The
peptides can also be joined by cross-linking the fourth and third
amino acids (4–3 link) (Fig. 1A) through the action of bifunctional
or monofunctional (capable of only peptide cross-linking) PBPs.
The activity of these distinct factors must be coordinated to ensure
proper cell-wall synthesis. One method of coordination is the use
of large protein complexes, the elongation complex and divisome,
which mediate cell-wall biogenesis during cell elongation or di-
vision, respectively (2). The essential activity of these enzymes
makes them prime drug targets; indeed, PBPs and Ldts are inhibited
by carbapenems and penicillin (6, 7), which remains one of the most
clinically important drugs in use.
Although the biosynthesis and structure of PG have been in-
vestigated for decades, predominantly in organisms such as
Escherichia coli or Bacillus subtilis, the mechanisms that coordinate
the biochemical activities required to polymerize and modify the
cell wall remain incompletely understood. Moreover, much less
is known about PG synthesis in many pathogenic organisms,
including Mtb (2). However, previous studies in Mtb suggest that
PG synthesis in this pathogen does not strictly conform to the
E. coli paradigm. For example, E. coli has three bifunctional
PBPs [PBP1A, PBP1B, and PBP1C (3)], whereas Mtb has just
two [PonA1 and PonA2 (8)]. Additionally, PBP2 (known as
PBPA in mycobacteria) is a monofunctional PBP and is required
for cell elongation in E. coli, but instead seems to function in cell
septation in mycobacteria (3, 9).
The structure of PG is also different in Mtb than in E. coli:
Mycobacterial PG has an unusual prevalence of 3–3 peptide
linkages. The abundance of 3–3 cross-links in mycobacterial PG
throughout different growth stages (5) suggests that Ldts are
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active during normal growth; however, their cellular roles or reg-
ulation during growth and PG biogenesis remain largely unknown.
Whereas penicillins and cephalosporins target only enzymes that
produce 4–3 cross-links, Ldts can be targeted by carbapenems
(7). Recent work suggests that these agents might be far more
efficacious against both dividing and nondividing bacteria (10).
Although little is known aboutMtb’s five encoded Ldts (11), one,
LdtB, is implicated in antibiotic tolerance (11–13), is required for
normal virulence in a mouse model of TB (12), and is important
for normal cell shape (13).
Previous studies have also revealed that PG biosynthesis dif-
fers between Mtb and the related saprophytic Mycobacterium
smegmatis (Msm). As opposed toMtb,Msm has three bifunctional
PBPs: PonA1, PonA2, and PonA3 (14). PonA1 is required for
Msm but not Mtb growth in culture (15, 16); however, PonA1 is
required for robust growth of Mtb during infection (16). In con-
trast, Mtb and Msm ponA2 mutants do not have growth defects in
culture (14, 17). However, Mtb strains with inactivated ponA1 or
ponA2 exhibit similar survival defects during growth in a host (16,
18), suggesting that these two similar bifunctional enzymes have
nonredundant and important contributions to PG synthesis during
infection. Collectively, the differences in PG synthase functionality
may imply that different PG synthetic pathways exist across spe-
cies, which may have consequences for a pathogen’s virulence
during infection.
Here, we interrogated PG synthesis in Mtb by investigating the
genetic interactions of ponA1, ponA2, and ldtB, which encode
three PG synthases critical for Mtb’s growth during infection. To
identify these interactions, we performed genome-wide transposon
mutagenesis screens inMtbmutant strains that lacked one of these
enzymes. Advances in high-throughput sequencing technology
coupled with the power of whole-genome studies provide unique
insights into key bacterial processes, such as cell-wall biosynthesis.
Such studies have been performed to a limited extent in bacteria,
and further work would substantially expand our understanding of
the organization of prokaryotic metabolic processes. In this study,
we identified diverse genetic interaction networks for ponA1,
ponA2, and ldtB, suggesting that these synthases are embedded
within distinct cellular networks for assembling Mtb’s PG. We
found that either ponA1 or ponA2 is required for cell growth, and
that ldtB interacts with both ponA1 and ponA2. Moreover, mu-
tants that lack these enzymes have differential susceptibility to
agents that interfere with cell-wall biogenesis. Thus, the Mtb cell
wall is synthesized using multiple interacting networks that are
both overlapping and unique.
Results
PonA1, PonA2, and LdtB Are Individually Dispensable for Growth of
Mtb. PonA1, its homolog PonA2, and LdtB can generate bonds
between new PG subunits and those in the existing PG polymer
(Fig. 1A). We generated independent ponA2 and ldtB deletion
mutants and assessed their growth. As suggested by previous
studies (14, 18) absence of either gene did not substantially affect
Mtb’s exponential growth, although loss of LdtB diminished pop-
ulation density in stationary phase (Fig. 1B). However, ΔponA2 cells
were moderately wider than wild-type Mtb (Fig. 1C). In contrast,
ΔponA1 cells are longer than wild-type cells (16), suggesting
these two homologous enzymes have distinct roles in PG synthesis
in Mtb. Mutant cells that lack LdtB were significantly shorter [as
previously reported (13)] and wider than wild-type cells (Fig. 1D),
indicating that LdtB affects cell-wall synthesis and cell shape in a
manner distinct from the two bifunctional PBPs. Thus, even
though deletion of ponA1 (16), ponA2, or ldtB is compatible with
cell growth, their individual deletions have detectable and dis-
tinct physiological effects.
Whole-Genome Mutagenesis Identifies PG Biogenesis Pathways in
Mtb. In E. coli, the PonA1 and PonA2 homologs, PBP1a and
PBP1b, seem to function in different subcellular complexes and
have been shown to have distinct interaction partners (3). We
hypothesized that, in a similar fashion, PonA1 and PonA2 genetically
interact with different pathways. To elucidate the shared and
distinct roles of PonA1, PonA2, and LdtB in Mtb PG biogenesis,
we used transposon mutagenesis and high-throughput sequencing
in ΔponA1, ΔponA2, and ΔldtB Mtb strains to define the genetic
interactions of these enzymes on a genome-wide scale (19, 20)
(Figs. S1 and S2). These experiments measure bacterial fitness
across a population. Genes that contain fewer than expected
transposon insertions have a growth disadvantage (here termed
“essential”) whereas those with larger numbers of insertions have
an advantage (“enriched”). Comparisons of the transposon in-
sertion profiles (21, 22) of the wild-type and mutant strains
revealed both essential and enriched genes—two types of genetic
interaction—in each strain (Fig. 2).
We identified 10 factors required in cells that lack PonA1 (Fig.
2A, essential factors). Most of these factors are associated with
or predicted to be involved in cell-wall synthesis. For example,
factors involved in peptidoglycan (PonA2), mycolic acid (MmaA4),
and, potentially, arabinogalactan (CpsY) synthesis in addition to
cell-wall precursor production (Rv1086) were found to be required
in ΔponA1 cells (Fig. 2A). These data suggest that the cell requires
either PonA1 or PonA2 for PG synthesis, analogous to the situa-
tion in E. coli (3). We also identified eight factors whose disruption
in the ΔponA1 mutant seemed beneficial to the cell (Fig. 2A,
enriched). For example, the transcription factor EspR (rv3849) had
higher levels of transposon insertions in cells that lack ponA1
Fig. 1. Deletion of PG synthases influences growth and morphology ofMtb.
(A) Transglycosylation (TG) and transpeptidation (TP) reactions incorporate
new PG subunits into the cell wall. PonA1 and PonA2 carry out both TG and
4–3 TP reactions. LdtB only mediates 3–3 TP reactions. M, N-acetylmuramic
acid. G, N-acetylglucosamine. (B) Deletion of either ponA2 or ldtB does not
greatly affect Mtb growth during log phase, although loss of ldtB reduces
population density in stationary phase. Error bars are often too small to see.
(C) ponA2 mutant cells (n = 179) have increased width compared with wild-
type cells (n = 153) (approximate P value <0.0001 by the Kolmogorov–Smirnov
test). (D) ldtB mutant cells (n = 193) have increased width and decreased
length compared with wild-type cells (n = 153) (approximate P value <0.0001
by the Kolmogorov–Smirnov test for both length and width).
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compared with wild-type Mtb, suggesting that cells that lack EspR
may grow more rapidly than wild-type cells under these condi-
tions. This could indicate that EspR regulates ponA1 transcription.
Indeed, we found multiple canonical EspR binding sites (23) in
the ponA1 promoter region (Fig. S3).
Our screen identified widely different genetic connections for
ponA2 compared with ponA1. As predicted from the screen per-
formed in ΔponA1 cells, ponA1 was required in ΔponA2 cells (Fig.
2B). Relatively few factors were shared between ΔponA1 and
ΔponA2 cells. For example, rv3490 and rv1248c were required in
both backgrounds. However, there were many differences, such as
cpsY, rv1086, pra, and fadB, and the differences were in both the
essential and enriched classes (Fig. 2 A and B). Thus, although
either PonA1 or PonA2 is required for Mtb growth, both enzymes
have predominantly different genetic interactions.
ldtB also interacts with a number of loci including some, such
as ponA2, that overlap with ponA1 interactions (Fig. 2C). In the
absence of either of the bifunctional enzymes that form 4–3
cross-links, 3–3 cross-linking may become more important for
maintaining cell integrity. In addition, ldtB interacts with genes
involved in cell-wall precursor synthesis (treS) and other steps
in peptidoglycan metabolism, including the NlpP60 hydrolase
Rv2190c (24). Collectively, these data show that the PG synthases
PonA1, PonA2, and LdtB participate in largely distinct genetic
networks (Fig. 2D).
PG Synthases Are Variably Required in ponA1, ponA2, or ldtB Mutant
Cells. We took advantage of the depth and saturation of the
mutant libraries to establish the relative contributions of PBPs
and Ldts to bacterial fitness in the different mutant strain back-
grounds. We analyzed the frequency of transposon insertions in
the four PBP and five Ldt loci as well as a putative penicillin
binding protein (Rv2864c) in each mutant strain. We found that
particular PG synthases had differential insertion profiles in cells
that lack ponA1, ponA2, or ldtB (Fig. 3). For example, transposon
disruption of pbpA generated a relative growth disadvantage in
ponA1 mutant cells compared with wild type whereas trans-
poson disrupted pbpA exhibited growth advantages in ponA2
and ldtB mutant cells. These data suggest that PBPA may be
more important for PG synthesis in cells without PonA1 than in
cells without PonA2 or LdtB. Our data also support a role for
rv2864c in PG synthesis. In ponA1 mutant cells, rv2864c was dis-
rupted at just 15% of the wild-type frequency but was disrupted at
82% or 51% of the wild-type frequency in ponA2 or ldtB mutant
cells, respectively (Fig. 3).
PonA2 Is Required for PG Synthesis in the Absence of PonA1. We
chose select genes for individual validation of essentiality using
a previously described allelic exchange method (16, 25) (Fig. 4A
and Fig. S4). For example, we generated a ponA2 deletion in a
strain whose only copy of ponA1 is at the L5 phage integration
site (ΔponA1 L5::ponA1wt). We also generated a ponA2 deletion
in wild-type H37Rv Mtb as a control. We assessed the impact of
ponA2 loss in the mutant background and found that ΔponA1
L5::ponA1wt ΔponA2 cells grew at rates similar to and exhibited
rod-shaped morphology similar to wild-typeMtb (Fig. S5 A and B).
However, although we could integrate a wild-type ponA1 copy into
the L5 site in ΔponA2 or ΔponA1 L5::ponA1wt ΔponA2 backgrounds
Fig. 2. ponA1, ponA2, and ldtB have largely distinct genetic interactions. Loci whose sequence reads were significantly different between wild-type and
mutant cells [(A) ΔponA1, red circles; (B) ΔponA2, blue circles; (C) ΔldtB, green circles] with a P value <0.001 (represented by the dotted line) by the Mann–
Whitney u test are plotted according to their P value and fold change in sequence reads from wild type (calculated from the geometric mean). Gray circles,
nonsignificant loci. Gray circles above the dotted line are loci that are <90% significant in the simulations (SI Materials and Methods). (D) Venn diagram
representation of the distinct interaction networks of ponA1, ponA2, and ldtB.









(Fig. 4B and Fig. S6A), when we transformed an L5 empty vector
we only obtained a significant number of colonies in the ΔponA2
cells that still encode ponA1 at the original locus (Fig. 4B and
Fig. S6A). This confirms that PonA2 is required in the absence of
PonA1 in Mtb and that even though these enzymes participate in
largely distinct genetic networks they have at least partially com-
plementary roles in PG biogenesis in Mtb.
Rv1086 Is Required for Cell-Wall Synthesis in Cells That Lack PonA1.
Rv1086, a Z-isoprenyl diphosphate synthase, carries out the first
committed step in the synthesis of the lipid carrier for cell-wall
precursors (26). As with ponA2, we used allelic exchange to test
whether rv1086 was required in cells that lack ponA1 (Fig. 4C).
Indeed, we obtained robust growth only when we transformed
ΔponA1 L5::ponA1wt Δrv1086 cells [which grew similarly to and
exhibited cell shape similar to wild-type Mtb (Fig. S5 C–E)] with
another ponA1 copy (Fig. 4D and Fig. S6B). These data dem-
onstrate that rv1086 is required in cells that lack ponA1 and may
indicate that PonA2 requires a dedicated pool of precursors.
LdtB Is Critical for Normal Bacterial Fitness in Cells Without PonA1.
An important prediction of the findings from our ΔponA1 and
ΔponA2 screens is that both strains require ldtB for optimal
growth (Fig. 4E and Fig. S7). Whereas bifunctional PBPs are crit-
ical in many bacterial species (3), mycobacterial PG exhibits very
different architecture with its prevalence of 3–3 cross-links (4, 5).
Using allelic exchange, we found that only tiny ΔponA1 ΔldtB
colonies could be seen after 21 d of growth, when ΔldtB colonies
were already large (Fig. 4F and Fig. S6C); these colonies required
35 d to reach a similar size (Fig. S6D). Thus, ldtB is required for
robust growth in the absence of ponA1.
Distinct Cell-Wall Synthesis Networks Exhibit Differential Tolerance to
Cell-Wall–Active Drugs. Our data suggest that PonA1, PonA2, and
LdtB participate in distinct genetic networks with partially over-
lapping but largely unique genetic interactions for each enzyme.
We hypothesized that these networks would have different cel-
lular activity and could therefore be differentially susceptible to
drugs that target cell-wall synthesis. To test this hypothesis, we
treated cells that lack ponA1, ponA2, ldtB, or other members of
their interaction networks with drugs that inhibit the various
components ofMtb’s cell wall, including meropenem, which blocks
PG transpeptidases; teicoplanin, which binds directly to PG to
prevent further cross-linking (10, 27); ethambutol, which targets
arabinogalactan synthesis; and isoniazid, which targets mycolic
acid synthesis. We found that ΔponA1 cells had the same mini-
mum inhibitory concentration (MIC) for meropenem and teico-
planin as wild-type Mtb (Fig. 5); however, ΔponA2 and ΔldtB cells
were four- to eightfold more susceptible to both meropenem and
teicoplanin. Furthermore, mutants that lack ponA1 exhibit a
fourfold increased susceptibility to ethambutol. However, the
ΔponA2 or ΔldtB mutants do not exhibit heightened sensitivity
to this antibiotic. ΔponA1, ΔponA2, or ΔldtB cells exhibited no
change in MIC when treated with SDS, and only ΔldtB cells were
slightly more sensitive to isoniazid. The Δrv1086 mutant was
eightfold more sensitive to teicoplanin and fourfold more sen-
sitive to meropenem and ethambutol compared with wild-type
Mtb (Fig. 5). Together, these data suggest that the enzymes that
comprise distinct PG synthetic networks have different roles in
antibiotic tolerance in Mtb.
Discussion
Cell-wall synthesis requires the collaboration of multiple en-
zymes. In most bacterial species, individual PBPs are dispensable.
This is generally interpreted as evidence of functional redundancy,
suggesting that enzymes have overlapping functions. Clearly, this is
not entirely true in both Msm and Mtb. In Msm, a single bi-
functional PBP, PonA1, is essential for normal growth, but ponA1
and ponA2 are both required for robust growth of Mtb during
infection. Our network analysis suggests that PonA1 and PonA2
are not identical—each is genetically associated with overlapping
and, importantly, unique factors. This may suggest that although
PonA1 and PonA2 mediate similar reactions, the pathways by
which each synthesizes PG are different. This likely has functional
consequences for bacterial growth in specific conditions. Indeed,
we found that mutant cells exhibit differential survival under
Fig. 3. Importance of PG synthases in ponA1, ponA2, or ldtB mutant cells.
Sequence reads corresponding to transposon insertions at the indicated loci
in the ΔponA1, ΔponA2, and ΔldtB mutant cells. Sequence reads at each
locus are normalized to the respective locus in wild-type H37Rv cells.
Fig. 4. Diverse cell-wall synthesis factors become required in ΔponA1 cells.
(A) Transposon insertions (vertical bars), determined from high-throughput
sequencing, are visualized at the ponA2 locus in either wild-type (gray) or
ΔponA1 (red) cells. (B) Colony-forming units (CFUs) were counted from allelic
exchanges with L5-integrating vectors that do or do not encode ponA1 in
the experimental ΔponA1 L5::ponA1wt ΔponA2 strain or the control ΔponA2
strain (both control strain transformations had lawn growth, and CFUs were
arbitrarily set to 6,000). (C) Transposon insertions at the rv1086 locus in wild-
type (gray) and ΔponA1 (red) cells. (D) CFU counts from L5 allelic exchanges
in the experimental ΔponA1 L5::ponA1wt Δrv1086 strain or the control
Δrv1086 strain. (E) Transposon insertions at the ldtB locus in wild-type (gray)
or ΔponA1 (red) cells. (F) CFU counts from L5 allelic exchanges in the ex-
perimental ΔponA1 L5::ponA1wt ΔldtB strain.
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antibiotic treatment, suggesting that cell-wall synthesis enzymes,
even closely related homologs, exhibit different functionality
during Mtb growth. This is likely true for other bacterial species
as well. Furthermore, we found that both ponA1 and ponA2 are
genetically associated with ldtB. This suggests that the bifunc-
tional PBPs function together with this major 3–3 transpeptidase
to synthesize new PG during growth.
What do these genetic interactions mean? They may imply
separate biochemical pathways that, for example, provide pre-
cursors to PonA1 and PonA2. Several pieces of evidence indicate
that PonA1 and PonA2 have distinct cellular roles, including
their susceptibilities to host-like stresses or infection (14) as well
as structural differences (28) and different impacts on cell shape
(Fig. 1) (16). These data may support a model wherein PonA1
and PonA2 exist in different subcellular complexes (3). Our
genetic analyses also support different cellular roles for PonA1
and PonA2. Notably, few interactions were identical for ponA1
and ponA2, suggesting their cellular activities are not truly re-
dundant (Fig. 6). Because a fully redundant system would un-
likely be maintained through evolution, there is likely some
selective advantage to having multiple independent systems for
PG synthesis (in Mtb and other organisms). There could be
several reasons for this. For example, these proteins could be
individually regulated, either transcriptionally or by substrate
availability provided by proteins lying within dedicated synthesis
pathways. This could result in altered rates of PG formation and,
consequently, growth, or could result in a different structure of
PG. For example, loss of 4–3 cross-links could increase the im-
portance of 3–3 cross-links for cell-wall integrity. This model is
consistent with the relative importance of ldtB, one of the major
3–3 cross-linking enzymes, with loss of either ponA1 or ponA2.
ldtB is the single Ldt that becomes critical for growth in the
absence of ponA1 or ponA2 (Fig. 3). The genetic interaction be-
tween the bifunctional PBPs and ldtB suggests that these enzymes
together promote new cell-wall synthesis during growth. This may
indicate that new glycan strands (synthesized by PonA1 or PonA2)
are predominantly first cross-linked in a 3–3 manner (for example,
by LdtB). This model is supported by the prevalence of 3–3 cross-
links in mycobacterial PG at all growth stages (5). Our data also
show that LdtB is critical for the maintenance of normal cell
shape (Fig. 1), which suggests that LdtB holds a key role in cell-
wall synthesis. Such 3–3 peptide cross-links, which also exist in
other bacteria, may provide increased structural integrity to the
cell during adverse conditions.
Whereas the cellular changes brought about by mutation are the
ends of the spectrum, it is likely that the balance between PonA1
and PonA2 activity is altered under different growth conditions.
This produces bacilli that can closely adapt to particular growth
conditions. For example, although there is little effect on growth
rate in culture, loss of PonA1 or PonA2 results in attenuation
during murine infection. This could be associated with changes in
cell morphology that are observed even in culture or could be
specific for interactions between the cell wall and the host.
A specific example of adaptation is the presence of antibiotics.
Mutant cells have altered susceptibility to some antibiotics (Figs. 5
and 6). It is possible that this is due to altered bacterial perme-
ability. However, these differences are mainly specific for drugs
that affect the synthesis of cell-wall components and not the de-
tergent SDS, suggesting that increased susceptibility is actually
caused by changes in the requirement for specific cell-wall synthetic
enzymes in the presence of mutations. The differential antibiotic
response of ponA1 and ponA2 mutant cells further supports a
model wherein they exist in separate PG synthesis pathways. For
example, ponA2mutant cells are more sensitive to meropenem and
teicoplanin than ponA1mutant cells. This suggests that these drugs
may more efficiently inhibit the active enzymes in ΔponA2 cells
(including PonA1) than the remaining enzymes in ΔponA1 cells.
These observations suggest that inhibition of PG synthesis by
transpeptidase inhibitors such as β-lactam or glycopeptide antibi-
otics could synergize with other cell-wall biosynthesis inhibitors and
increase their efficacy. Understanding the pathways involved could
help to design such synergistic pairs of inhibitors—forMtb as well as
other bacterial pathogens, many of which have not been subjected
to similar studies. Efforts to target these pathogens could ulti-
mately profit from similar strategies to identify novel members of
key metabolic pathways and define individual contributions to
antibiotic tolerance.
Materials and Methods
Bacterial Strains and Growth Conditions. M. tuberculosis H37Rv and E. coli
Top10 (Invitrogen; used for cloning) were cultured as in ref. 16. The construction
of the ΔponA1 and ΔponA1 L5::ponA1wt Mtb strains was described in ref. 16.
Transposon Mutagenesis. The H37Rv transposon libraries were generated
using the ϕMycoMarT7 phagemid as previously described (29).
Genomic Library Construction and High-Throughput Sequencing. Genomic DNA
(gDNA) was harvested from the transposon libraries and prepared for PCR
amplification as described (19). PCR-amplified transposon–gDNA junctions
were then subjected to high-throughput sequencing (Illumina). For additional
details of library preparation and data analysis, see SI Materials and Methods.
Mapping and Counting Transposon Insertions. Sequence data were filtered for
transposon-specific information and trimmed of transposon sequence except
for the TA dinucleotide insertion site with custom Python scripts (SI Appendix,
sections 1, 2, and 3). Trimmed reads were mapped to the H37Rv genome
using Bowtie2 (30). Insertions at each genomic TA site were counted with
custom Python scripts (SI Appendix, sections 4 and 5).
Analysis of Differentially Inserted Genes. Loci that were differentially disrupted
betweenwild-type andmutant cells were assessed as in ref. 22 (Dataset S1).We
used the Mann–Whitney u test and simulation-based normalization without
the hidden Markov model (HMM) (22). For each library’s locus, the geometric
Fig. 5. Differential susceptibility ofMtb cell-wall mutants to cell-wall–active
antibiotics. The fold change in MIC for the indicated drugs and SDS were
calculated compared with wild-type Mtb for the indicated strains.
Fig. 6. ponA1, ponA2, and ldtB are hubs of distinct cell-wall synthesis net-
works. Selected interactions with cell-wall synthesis genes discovered in whole-
genome screens (dashed lines) and/or by directed knockouts (solid lines) for
ponA1, ponA2, and ldtB. The members of these networks respond differently
to specific cell-wall drugs, such as teicoplanin and meropenem. For example,
meropenem may target PonA1 more (thicker “T”) than LdtB (thinner “T”).









mean of the sequence reads was calculated (Dataset S2) with a custom
MATLAB script using the encoded geomean function (SI Appendix, section 10).
Recombinant DNA Constructs and Gene Knockouts. ponA1 was subcloned into
the L5 pMC1s vector as in ref. 16. The ponA2 knockout cassette was ampli-
fied by PCR from a custom phage (31). The rv1086 and ldtB knockout cas-
settes consisted of 500 nucleotides 5′ or 3′ of rv1086 or ldtB flanking a
hygromycin cassette with PmeI sites at each end (Gen9). Digestion with PmeI
(New England Biolabs) generated linear recombineering products. The ponA2,
ldtB, and rv1086 deletions were generated in the ΔponA1 L5::ponA1wt strain
(16) via recombineering (for more details, see SI Materials and Methods).
Allelic Exchange in Mtb. Allelic exchange occurs as described (16, 23). The
ΔponA1 L5::ponA1wt loxed strain wherein ponA2, rv1086, or ldtB was de-
leted was used for allelic exchange. Simultaneous control transformations
with the same L5 vectors were performed in ΔponA2, Δrv1086, and ΔldtB
cells. Colony-forming units were counted at 21 d, except for the ΔponA1 L5::tetR
ΔldtB plate, which was counted at 35 d.
Optical Density Measurements. Population growth curves forMtb strains were
performed as in ref. 16.
Light Microscopy and Image Analysis. Cells were fixed overnight in 1% for-
malin at 4 °C in the Biosafety Level 3 facility. Cells were imaged and mor-
phology analyzed as in ref. 16. Final images were prepared in Fiji (32).
Antibiotic MIC Assays. The antibacterial effects of meropenem, teicoplanin,
ethambutol, isoniazid, and SDS (Sigma Aldrich) were determined as in ref. 16.
Data Representation and Statistical Analysis. Prism 6.0 (GraphPad Software)
was used tographandanalyzenumerical data. Statistical tests in Prism calculated
significance of measurements as reported in figure legends. The Venn diagram
was generated with BioVenn (33). Transposon insertions were visualized in
DNAplotter (34) or Artemis (35) by converting the insertion counts to appro-
priate data structures with custom Python scripts (SI Appendix, sections 8 and 9).
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